CD274 and non-small cell lung carcinoma: The upregulation of PD-L1 in NSCLC is well-characterized, and the typical mechanisms of PD-L1 upregulation mainly include JAK-STAT-IRF1/TLR4/MAPK/PI3K signaling to transcriptionally upregulate PD-L1 (10, 11).